(Q43058805)

13 November 2017

EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain? (English)

1 reference

13 November 2017

R Sesboüé

1

1 reference

13 November 2017

F Le Pessot

series ordinal

2

1 reference

13 November 2017

F Di Fiore

series ordinal

3

1 reference

13 November 2017

T Frebourg

series ordinal

4

1 reference

13 November 2017

language of work or name

English

0 references

publication date

20 December 2011

1 reference

British Journal of Cancer

13 November 2017

1 reference

13 November 2017

106

1 reference

13 November 2017

2

1 reference

13 November 2017

426-7; author reply 428

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2011.570

13 November 2017

0 references

cites work

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261662

An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathology

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261662

Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261662

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261662

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261662

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261662

Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261662

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3261662

15 August 2018

Identifiers

DOI

10.1038/BJC.2011.570

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

22187031

1 reference